What percentage of seed-stage startups make it to Series B?

What Percentage of Seed-Stage Startups Reach Series B?

Roughly 1-in-10 seed-stage companies make it to Series B. Depending on the data source, sector, and vintage year, that number sits somewhere between 8% and 15%. The honest answer lives in that band.

But the stat alone isn't actionable. The more important question is: why do 90% stall out — and what separates the companies that don't?

---

Why Most Seed-Stage Startups Never Reach Series B

The most common failure mode isn't a bad idea. It's a timing and capital problem:

• Running out of runway before finding product-market fit. Founders underestimate how long true PMF takes and over-index on growth before the signal is real.
• Raising the wrong round at the wrong time. A valuation that looks flattering at seed can become a ceiling that makes your Series A undoable — or crushes founder ownership if the business doesn't grow into it fast enough.
• Structural cap table problems. Stacked SAFEs feel cheap and convenient at pre-seed, but the dilution math can blow up a Series A before you ever get to the investor conversation.

---

Three Behaviors That Move You Into the 10%

1. Treat Fundraising as a Relationship, Not an Event

The founders who close Series A and B rounds fastest are the ones who were already in relationship with those investors 12–18 months earlier — sending updates, grabbing coffee, and explicitly not asking for money. By the time you open a formal round, the decision is nearly made.

2. Understand How Round Difficulty Actually Scales

For most founders, the hardest capital to raise is the very first check. Once you've proven you can raise and learned the mechanics, it gets relatively easier — until the Series A resets the difficulty entirely. Enterprise sales cycle proof, unit economics, and scale requirements all arrive at once.

3. Protect Your Cap Table from Day One

Every SAFE you stack at pre-seed is a future dilution event that lands at the worst possible moment: right when you need a clean, institutional-grade cap table to close a priced round. Model the conversion scenarios early and often.

---

"Most companies don't die because the idea was bad. They stall because they run out of runway before finding product-market fit, or they raise the wrong round at the wrong time and can't grow into their valuation."

---

The Takeaway

The 8–15% survival rate to Series B is a useful benchmark for calibrating expectations — not a fate. The founders who beat those odds share a common pattern: they manage capital discipline, build investor relationships long before they need them, and keep their cap table clean enough that institutional rounds stay mathematically viable.

Knowing the odds doesn't move the needle. Your behavior between now and your next raise does.